Viewing Study NCT02616666

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:39 PM
Ignite Modification Date: 2026-02-24 @ 2:06 PM
Study NCT ID: NCT02616666
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-12-16
First Post: 2015-11-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients
Sponsor: University of Liverpool
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 diabetes mellitus View
None Randomised View
None Pragmatic View
None Standard of Care View
None Dapagliflozin View
None FORXIGA View